Education
About Us
Working with TipRanks
Follow Us
Helix BioMedix (HXBM)
:HXBM
Total Valuation
Helix BioMedix has a market cap or net worth of $830.30K. The enterprise value is ―.
Market Cap$830.30K
Enterprise Value―
Share Statistics
Helix BioMedix has 224,708 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding224,708
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Helix BioMedix’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -33.27%.
Return on Equity (ROE)-0.36
Return on Assets (ROA)-0.35
Return on Invested Capital (ROIC)-33.27%
Return on Capital Employed (ROCE)-0.33
Revenue Per Employee124.72K
Profits Per Employee-132.01K
Employee Count8
Asset Turnover0.33
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Helix BioMedix is ―. Helix BioMedix’s PEG ratio is 0.43.
PE Ratio―
PS Ratio5.24
PB Ratio1.77
Price to Fair Value1.77
Price to FCF-6.00
Price to Operating Cash Flow―
PEG Ratio0.43
Income Statement
In the last 12 months, Helix BioMedix had revenue of 997.73K and earned -1.06M in profits. Earnings per share was -4.70.
Revenue997.73K
Gross Profit987.98K
Operating Income-984.05K
Pretax Income-1.06M
Net Income-1.06M
EBITDA-1.05M
Earnings Per Share (EPS)-4.70
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Helix BioMedix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.05
52-Week Price Change-76.28%
50-Day Moving Average4.13
200-Day Moving Average6.19
Relative Strength Index (RSI)19.61
Average Volume (3m)14.00
Important Dates
Helix BioMedix upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Helix BioMedix as a current ratio of 44.99, with Debt / Equity ratio of ―
Current Ratio44.99
Quick Ratio44.99
Debt to Market Cap0.00
Net Debt to EBITDA2.46
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Helix BioMedix has paid 5.00 in taxes.
Income Tax5.00
Effective Tax Rate>-0.01
Enterprise Valuation
Helix BioMedix EV to EBITDA ratio is -2.54, with an EV/FCF ratio of -3.05.
EV to Sales2.66
EV to EBITDA-2.54
EV to Free Cash Flow-3.05
EV to Operating Cash Flow-3.06
Balance Sheet
Helix BioMedix has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share$13.16
Margins
Gross margin is ―, with operating margin of -98.63%, and net profit margin of -105.85%.
Gross Margin―
Operating Margin-98.63%
Pretax Margin-105.85%
Net Profit Margin-105.85%
EBITDA Margin-104.87%
EBIT Margin-105.85%
Analyst Forecast
The average price target for Helix BioMedix is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―